Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.SummaryDifference10%

- Check28 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check42 days agoChange DetectedNew version v3.0.2 is released with a Study Status Contacts/Locations entry (dated 2025-09-08) and a page date of 2025-09-09, replacing the old 2025-08-11 entry and v3.0.1, while removing the Back to Top link.SummaryDifference2%

- Check49 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.6%

- Check56 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference44%

- Check71 days agoChange DetectedThe web page has been updated to a new version, v2.16.12, and the previous version, v2.16.11, has been removed. Additionally, a date of 2025-08-11 has been added.SummaryDifference1.0%

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.